Skip to content

Acupuncture for the reduction of paroxysmal atrial fibrillation duration: a randomized controlled clinical trial

Acupuncture for the reduction of paroxysmal atrial fibrillation duration: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006640
Enrollment
Unknown
Registered
2022-09-22
Start date
2022-09-23
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Acupuncture group:-
Sham acupuncture group:-

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?Symptomatic paroxysmal atrial fibrillation with at least 2 episodes in the past 6 months and at least 1 episode confirmed by ECG. ?No age limit, male or female. ?No acupuncture treatment within the previous 6 month. ?Cooperating with 8 weeks treatment and follow-up. ?Signed written informed consent.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had any of the following ?Secondary atrial fibrillation. ?Catheter ablation or cardiac surgery within the last 3 months. ?Severe heart failure (New York Heart Association (NYHA)III or IV). ?In the absence of a pacemaker, patients with sick sinus syndrome, II or III degree atrioventricular block. ?Echocardiography: left ventricular ejection fraction 5.5cm. ?Have severe lung, liver, kidney disease or other serious primary disease. ?Skin allergy to ECG monitoring electrodes. ?Patients enrolled in other clinical trials within the last 1 month. ?Patients enrolled in other clinical trials within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Change of AF burden compared to baseline at 6 months;

Secondary

MeasureTime frame
Heart rate variability;Quality of life evaluation;Times to hospitalizations for cardiac arrhythmias.;The maximum daily duration of AF during monitoring.;Total duration of atrial fibrillation during monitoring;European Heart Rhythm Society (EHRA) Atrial fibrillation symptom score.;Average heart rate;Change from baseline in AF burden at the end of treatment;

Countries

China

Contacts

Public ContactLiu Cunzhi
lcz_tg@126.com+86 10 53912201

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026